Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-1
Closed -$54K 141
2020
Q2
$54K Buy
+1
New +$434 0.01% 90
2020
Q1
Sell
-1
Closed -$31K 95
2019
Q4
$31K Hold
1
0.01% 67
2019
Q3
$28K Buy
+1
New +$342 0.02% 87
2016
Q1
Hold
0
-$105K 318
2015
Q4
Hold
0
296
2015
Q3
Hold
0
366
2015
Q2
Hold
0
305
2015
Q1
Sell
-1
Closed -$6.96K 268
2014
Q4
$907 Sell
1
-2
-67% -$13.9K 0.03% 163
2014
Q3
$2.42K Hold
3
0.09% 98
2014
Q2
$2.78M Hold
3
0.12% 83
2014
Q1
$2.55M Hold
3
0.14% 95
2013
Q4
$3.64M Buy
3
+2
+200% +$24K 0.23% 57
2013
Q3
$710K Buy
+1
New +$14.8K 0.05% 142
2013
Q2
Hold
0
166

Other funds holding IMNN

Sabby Management's IMNN Position: Q3 2025 in Review

Sabby Management sold out of Imunon (IMNN) in Q3 2025, closing a stake of 69,000 shares — an estimated $720K sold.

Sabby Management first reported a position in IMNN in Q1 2014 and held it in 21 quarters. The position peaked at $1.93M in Q2 2016. 17 funds tracked by Wall St. Rank hold IMNN as of Q3 2025.

  • Sabby Management reported no remaining Imunon position as of Q3 2025 after selling out during the quarter.
  • Sabby Management sold 69,000 Imunon shares in Q3 2025, an estimated $720K.
  • Sabby Management first reported a position in Imunon in Q1 2014 and held it in 21 quarters.
  • Sabby Management's Imunon position peaked at $1.93M in Q2 2016.
  • 17 funds tracked by Wall St. Rank held Imunon as of Q3 2025.

Based on Sabby Management's 13F filing for Q3 2025, filed 14 Nov 2025.